| Literature DB >> 35945795 |
Hyerim Kim1, Jimin Lee1, Sung Man Chang1,2, Byung-Soo Kim1,3.
Abstract
BACKGROUND: With the aging of the population, the number of people with age-related memory complaints has also increased. The purpose of this study was to develop a cognitive rehabilitation program based on mnemonic skills and memory compensatory strategies (CRM) and to investigate the effects of CRM in community-dwelling older adults without dementia.Entities:
Mesh:
Year: 2022 PMID: 35945795 PMCID: PMC9351895 DOI: 10.1097/MD.0000000000029581
Source DB: PubMed Journal: Medicine (Baltimore) ISSN: 0025-7974 Impact factor: 1.817
Contents of each cognitive rehabilitation program session based on mnemonic skills and memory compensatory strategies.
| Session | Mnemonic skills | Memory compensatory strategies |
|---|---|---|
| 1 | Word association with images 1 | Using a cellphone camera |
| 2 | Word association with images 2 | Managing schedules using a calendar, a note, or a board |
| 3 | Method of loci | Using an alarm |
| 4 | Method of body parts | Using a timer |
| 5 | Memorizing numbers | Taking important things when going out |
| 6 | Face-name association 1 | Using a storage box |
| 7 | Face-name association 2 | Taking medications without forgetting |
| 8 | Review: various ways of memorizing using both mnemonic skills and memory compensatory strategies together | |
Figure 1.Flowchart of study participants. We enrolled community-dwelling older adults aged over 60 years with normal cognitive function or with MCI. A total of 42 participants were recruited; among them, one participant with suspected dementia was excluded and three participants declined to participate before the program started. Thirty-eight participants (20 with normal cognitive function and 18 with MCI) participated in the program and six participants (four with normal cognitive function and two with MCI) dropped out because of refusal to participate in the program. Thirty-two participants finally completed the program and were assessed after the program.
Baseline demographic and clinical characteristics.
| Characteristics | CRM (n = 32) | ||
|---|---|---|---|
| Normal (n = 16) | MCI (n = 16) |
| |
| Age (y) | 68.63 ± 4.40 | 70.88 ± 5.34 | .445 |
| Female | 13 (81.3%) | 13 (81.3%) | 1.000 |
| Education (y) | 8.38 ± 4.29 | 9.50 ± 4.02 | .642 |
| SMCQ | 4.94 ± 3.44 | 6.56 ± 3.12 | .171 |
| SGDS-K | 4.31 ± 5.17 | 1.94 ± 2.44 | .323 |
| EQ-5D | 0.82 ± 0.13 | 0.90 ± 0.06 | .056 |
| EQ-VAS | 71.13 ± 16.30 | 67.63 ± 22.15 | .926 |
| CERAD-K | |||
| CFT | 13.00 ± 2.66 | 12.81 ± 3.73 | .956 |
| BNT | 11.63 ± 2.60 | 10.75 ± 2.46 | .305 |
| MMSE-KC | 27.88 ± 2.22 | 27.63 ± 2.45 | .752 |
| WLMT | 20.06 ± 3.11 | 20.06 ± 3.45 | 1.000 |
| WLRT | 6.56 ± 1.41 | 6.13 ± 1.71 | .724 |
| WLRcT | 9.19 ± 1.28 | 8.69 ± 1.66 | .381 |
| CPT | 10.38 ± 1.15 | 6.50 ± 3.83 | .002 |
| CRT | 7.13 ± 3.05 | 7.94 ± 3.44 | .402 |
| TMT-A (s) | 66.00 ± 49.92 | 100.63 ± 86.00 | .073 |
Comparisons between pre and post outcomes in older adults with normal cognitive function* (n = 16).
| Outcome measure | Pre | Post | Z |
|
|
|---|---|---|---|---|---|
| SMCQ | 4.94 ± 3.44 | 4.69 ± 3.59 | −0.398 | .691 | −0.070 |
| SGDS-K | 4.31 ± 5.17 | 3.50 ± 5.30 | −1.178 | .239 | −0.208 |
| EQ-5D | 0.82 ± 0.13 | 0.85 ± 0.13 | −1.140 | .254 | −0.202 |
| EQ-VAS | 71.13 ± 16.30 | 74.69 ± 17.84 | −1.029 | .304 | −0.182 |
| CERAD-K | |||||
| CFT | 13.00 ± 2.66 | 14.13 ± 4.10 | −1.000 | .317 | −0.177 |
| BNT | 11.63 ± 2.60 | 11.94 ± 2.24 | −0.855 | .393 | −0.151 |
| MMSE-KC | 27.88 ± 2.22 | 27.31 ± 1.92 | −1.920 | .055 | −0.339 |
| WLMT | 20.06 ± 3.11 | 22.44 ± 3.31 | −2.407 | .016 | −0.426 |
| WLRT | 6.56 ± 1.41 | 7.31 ± 1.82 | −1.968 | .049 | −0.348 |
| WLRcT | 9.19 ± 1.28 | 9.69 ± 0.79 | −1.841 | .066 | −0.325 |
| CPT | 10.38 ± 1.15 | 10.56 ± 0.81 | −0.351 | .726 | −0.062 |
| CRT | 7.13 ± 3.05 | 7.44 ± 3.65 | −0.616 | .538 | −0.109 |
| TMT-A (s) | 66.00 ± 49.92 | 60.94 ± 30.08 | −0.284 | .776 | −0.050 |
Comparisons between pre and post outcomes for each program group in the elderly with mild cognitive impairment* (n = 16).
| Outcome measure | Pre | Post |
|
|
|
|---|---|---|---|---|---|
| SMCQ | 6.56 ± 3.12 | 5.69 ± 3.44 | −1.188 | .235 | −0.210 |
| SGDS-K | 1.94 ± 2.44 | 1.31 ± 1.62 | −0.787 | .431 | −0.139 |
| EQ-5D | 0.90 ± 0.06 | 0.88 ± 0.09 | −1.024 | .306 | −0.181 |
| EQ-VAS | 67.63 ± 22.15 | 70.94 ± 10.99 | −0.710 | .478 | −0.126 |
| CERAD-K | |||||
| CFT | 12.81 ± 3.73 | 13.81 ± 2.71 | −1.191 | .234 | −0.211 |
| BNT | 10.75 ± 2.46 | 12.06 ± 2.72 | −2.623 | .009 | −0.464 |
| MMSE-KC | 27.63 ± 2.45 | 27.94 ± 1.65 | −0.668 | .504 | −0.118 |
| WLMT | 20.06 ± 3.45 | 20.63 ± 3.65 | −1.031 | .303 | −0.182 |
| WLRT | 6.13 ± 1.71 | 7.00 ± 1.41 | −1.767 | .077 | −0.312 |
| WLRcT | 8.69 ± 1.66 | 9.56 ± 0.81 | −2.401 | .016 | −0.424 |
| CPT | 6.50 ± 3.83 | 9.13 ± 2.68 | −2.807 | .005 | −0.496 |
| CRT | 7.94 ± 3.44 | 9.38 ± 2.75 | −2.501 | .012 | −0.442 |
| TMT-A (s) | 100.63 ± 86.00 | 73.38 ± 36.72 | −2.131 | .033 | −0.377 |